Next-Generation Clot Removal System with AI-Enabled Micro-Agents

A revolutionary clot removal system leveraging nanorobotics, AI-driven navigation, and bio-inspired materials to enable minimally invasive, real-time clot monitoring and removal, potentially replacing traditional thrombectomy devices.

The original patent for clot retrieval devices, while effective, has limitations in terms of invasiveness, clot engagement, and real-time monitoring. The new inventive concept addresses these limitations by introducing AI-enabled micro-agents, swarm robotics, and self-healing materials to provide a more effective, minimally invasive, and real-time clot removal solution.

The next-generation clot removal system comprises a nanorobot-enabled clot retrieval device with a swarm of micro-agents that can be deployed to a blood vessel to break down and remove a clot. The micro-agents are equipped with nanoscale propellers and clot-digesting enzymes, guided by a neural network-based navigation system that facilitates real-time clot monitoring. The system also includes a wearable, non-invasive brain-computer interface for detecting ischemic stroke or pulmonary embolism in real-time, triggering the deployment of the clot removal device. Additionally, the system can be integrated with machine learning algorithms to analyze patient medical history and detect risk factors for thromboembolism, enabling prophylactic clot prevention.

The new claims introduce the use of nanorobotics, swarm robotics, AI-driven navigation, and bio-inspired materials, which are not present in the original patent. These innovations provide a paradigm shift in clot removal technology, enabling minimally invasive, real-time clot monitoring and removal, and potentially making traditional thrombectomy devices obsolete.

Alternative embodiments of the inventive concept could include the use of different types of micro-agents, such as those equipped with ultrasound or optical sensors for enhanced clot detection. Variations could also include the integration of the system with other medical devices, such as stents or catheters, to provide a comprehensive vascular intervention platform.

The next-generation clot removal system has significant commercial potential in the medical device industry, particularly in the areas of stroke and pulmonary embolism treatment. The system's minimally invasive nature, real-time clot monitoring capabilities, and potential for prophylactic clot prevention make it an attractive solution for hospitals, clinics, and medical research institutions.